ABSTRACT Cysteamine has been reported to modulate energy homeostasis and exert significant growthpromoting effects in broiler chickens. However, little is known concerning its effects on egg production of hens and the growth rate of their offspring. In the present study, 67-wk-old broiler breeders were allotted at random to control and cysteamine-supplemented (400 mg/ kg) groups for 8 wk. The hatchlings were fed under the same condition until 6 wk of age. Cysteamine significantly increased the average laying rate by 2.24% (P < 0.01), decreased dramatically the percentage of the broken eggs by 40.55% (P < 0.01), and increased that of the abnormal eggs by 20.15% (P < 0.05). Cysteamine did not alter the egg weight, egg quality, fertility, or hatchability but significantly increased eggshell weight (P < 0.05) and decreased albumin weight (P < 0.05). Serum concentrations of total thyroxine (P < 0.01) and leptin (P < 0.01) were significantly lower in cysteamine-treated hens, whereas total triiodothyronine (T 3 ), free T 3 , and glucagon were not affected. Western blot analysis with leptin-specific antibody detected a band of approximately 15 to 16 kDa in egg yolk and albumin extracts as well as in liver homogenates of hens. Cysteamine did not affect the yolk content of T 3 , thyroxine, estradiol, or glucagon, but significantly increased leptin content in liver of hens (P < 0.05), as well as in yolk (P < 0.05) and albumin (P < 0.05) of eggs. These changes were accompanied by a significant downregulation of leptin receptor mRNA expression (P < 0.05) in the yolk sac of d-12 embryos. Female offspring hatched from cysteamine-treated eggs demonstrated significantly lower body weight at hatching (P < 0.01) and 42 d of age (P < 0.01). The results indicate that cysteamine improves laying performance of hens and affects the early posthatch growth of broiler offspring, in a sex-specific fashion. The modified leptin secretion and egg deposition, together with altered yolk sac leptin receptor expression, may be involved in such an effect.
INTRODUCTION
Cysteamine (NH 2 -CH 2 -CH 2 -SH, β-mercaptoethylamine), a naturally existing bioactive substance, is known to modulate the endocrine and metabolic status of animals (Rideau et al., 1990; McLeod et al., 1995a,b) via depleting the endogenous somatostatin (Brown et al., 1983) . It has been demonstrated that cysteamine improves growth rate, inhibits fat deposition, and promotes muscle accretion in fish (Xiao and Lin, 2003; Tse et al., 2006) and chicken (Yang et al., 2006) . Modification of endocrine status influences not only growth but also reproductive functions, both in mammalian (Gong, 2002) and avian species (Bedrak et al., 1981; Hocking et al., 1994; Paczoska-Eliasiewicz et al., 2006) . Cysteamine was reported to promote the maturation and fertilization of oocytes and to improve embryo developmental rates in vitro (de Matos and Furnus, 2000; Urdaneta et al., 2004) . However, no data are available regarding the in vivo effect of cysteamine on laying performance of hens.
Developmental exposure to hormones or endocrine disrupters can program the postnatal performance of offspring (Newbold et al., 2007) . Several hormones, including growth hormone (Rehfeldt et al., 2004) , leptin (McMillen et al., 2006) , and glucocorticoid (Seckl and Holmes, 2007) are implicated to participate in such programming. Although the growth-promoting dose of cysteamine is less than one-tenth of the level showing developmental toxicity , the modified endocrine status by cysteamine treatment may influence the performance of progeny.
Birds provide an excellent model for investigating the maternal influence or developmental programming, because the egg serves as the only vehicle to convey the signals from mother to offspring during embryonic development (Groothuis et al., 2005) . Altera-tions of endocrine status of hens may change the yolk deposition of maternal hormones and thus program the offspring growth (De Pablo et al., 1982; Wilson and McNabb, 1997; Eising et al., 2003; Hayward and Wingfield, 2004) .
Therefore, the objectives of the present study were to investigate the effect of dietary supplementation of cysteamine on laying performance of broiler breeder hens during the late (postpeak) stage of the laying cycle and to explore whether maternal exposure to cysteamine could affect offspring growth during early posthatch development. The serum and yolk concentrations of some metabolic hormones were measured to identify hormone(s) that may mediate the maternal effect of cysteamine.
MATERIALS AND METHODS

Birds and Experimental Design
Sixty 7-wk-old San Huang broiler breeders (a local crossbred broiler breed) at the postpeak stage of the laying cycle were raised in a commercial breeding hennery (Wen's group, Guangdong, China) and allocated randomly into 2 groups (8 replicates/group, 30 hens/ replicate). Hens in cysteamine-treated group received a diet supplemented with a commercial cysteamine feed additive (supplied by Shanghai Walcom Bio-Chem Co. Ltd., Shanghai, China, containing 30% of cysteamine hydrochloride with starch and dextrine as carriers for stabilization) at the level of 400 mg/kg, which is recommended by the company for improving laying performance in hens, whereas those in the control group received the basal diet supplemented with the same amount of starch and dextrine. The hens were housed at 22 ± 1°C with a 15L:9D light regimen and allowed free access to water. The diets used in the present experiment were formulated according to the nutritional requirements of the breed recommended by the breeding company, and the amount supplied per hen per day was determined based on egg-laying rate and maintenance requirements (Table 1 ). The experiment lasted for 8 wk. Eggs were collected, and the laying performance including the egg-laying rate, the percentages of abnormal eggs and broken eggs, and the average egg weight was recorded on a daily basis. Soft-shell and cracked-shell eggs were regarded as broken eggs, and eggs with intact eggshell but abnormal shape or weight were counted as abnormal eggs. One hundred forty eggs from each group were collected randomly from the last 3 d of the fifth week after the dietary treatment and incubated in a commercial hatchery. The fertile egg rate, the hatch rate of fertile eggs, and the hatch rate of incubated eggs were recorded. The newly hatched chicks were fed ad libitum the same starter and grower diets under the same standard condition from 1 to 21 d of age and from 22 to 42 d of age, respectively ( Table 1) . The growth performance of the offspring was recorded weekly until 42 d of age.
Egg quality and yolk content of hormones were measured from 50 eggs collected randomly from each group after 5 wk of treatment. At the beginning of the sixth week of treatment, 10 hens from each group were weighed and killed. Blood and liver samples were collected for hormone analysis. Liver and oviduct were removed and weighed. The oviduct weight and the number of hierarchical follicles in ovary were recorded. Yolk sac membranes of d-12 embryos were collected and snap-frozen in liquid nitrogen and kept in −80°C for quantification of gene expression. The experiment was undertaken following the guidelines of Animal Ethics Committee in Nanjing Agricultural University, China.
Tissue Extraction and Hormone Measurement
Frozen liver samples (~200 mg) were homogenized in 2 mL of ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 0.2% Triton X-100 and protease inhibitor mixture) using a tissue grinder (Polytron, Polytron PT1200E; Brinkman Instruments, Littau, Switzerland). The homogenate was then centrifuged at 5,000 × g for 20 min at 4°C to remove all insoluble material. The supernatant was collected, and the protein concentration was determined with a Bradford assay kit purchased from Nanjing Jiancheng Biotechnology Institute (Nanjing, China).
Egg yolk samples were subjected to a methanolchloroform extraction procedure (Wilson and McNabb, 1997) and reconstituted with 75% ethanol before thyroid hormone analysis. An ice-cold acetic acid-ethanol extraction procedure (De Pablo et al., 1982) was applied before measuring yolk and albumin content of glucagon and leptin. Serum concentrations of 17β-estradiol (E 2 ), triiodothyronine (T 3 ), thyroxine (T 4 ), and free T 3 were measured with RIA using commercial kits purchased from Beijing Institute of Biological Products (Beijing, China). Leptin and glucagon concentrations were measured with respective commercial multispecies RIA kits purchased from Beijing North Institute of Biotechnology (Beijing, China). The detection limits for leptin and glucagon were 0.45 ng/mL and 16.1 pg/ mL, respectively. The intra-and interassay coefficients of variation were 5 and 10%, respectively, for both kits. The commercial RIA kits were both validated for measuring chicken samples previously (Li et al., 2007) .
Western Blot Analysis of Leptin in Liver and Egg Extracts
Eighty micrograms of protein extract was mixed with loading buffer and denatured by boiling for 5 min before being loaded on a 15% SDS-PAGE gel. After electrophoresis, proteins were transferred to nitrocellulose membranes, and the latter were then blocked with 5% fat-free milk in Tween-Tris-buffer saline for 2 h at room temperature. After repeated washing with Tween-Trisbuffer saline, the membranes were incubated with polyclonal antibodies against leptin (ab3583, Abcam, Cambridge, UK; diluted 1:4000), followed by horseradish peroxidase-conjugated secondary antibodies (ab6721-1, Abcam; diluted 1:5,000), as described previously (Kochan et al., 2006) . Finally, the membrane was washed and the specific signals were detected by chemiluminescence using the LumiGlo substrate (Super Signal West Pico Trial Kit, Pierce, Rockford, IL). Enhanced chemiluminescence signals recorded on xray film were scanned and analyzed with Kodak 1D Electrophoresis Documentation and Analysis System 120 (Kodak Photo Film Co. Ltd., Rochester, NY). The membranes were stripped and reprobed with antibody against β-actin (ab8227, Abcam, UK; diluted 1:4,000). The leptin content in tested samples was presented as the band density values of leptin relative to β-actin.
The polyclonal leptin antibody (ab3583) was raised against a synthetic peptide corresponding to amino acids 25 to 44 of mouse leptin (QKVQDDTKTLIK-TIVTRIND). This sequence is highly conserved in vertebrates, including human, mouse, rat, carp, duck, turkey, and chicken. Recombinant chicken, mouse, and human leptin were loaded (50 ng per lane) for Western blot analysis as positive controls. Recombinant chicken leptin was a generous gift from Zhendan Shi at South China Agricultural University, Guangdong, China. Recombinant mouse leptin was purchased from R&D Systems (498-OB-01M, Minneapolis, MN). Recombinant human leptin was purchased from No. 301 Military Hospital (Beijing, China).
RNA Extraction and mRNA Quantification
Total RNA was extracted from yolk sac using TRNzol Total RNA Kit (Tiangen Biotech Co. Ltd, Beijing, China), according to the recommendations of the manufacturer. Two micrograms of total RNA was reverse-transcribed in a final volume of 25 μL of M-MLV reverse transcriptase (M1701, Promega, Madison, WI) and random hexamer primers (SunShine, Nanjing, China). Reverse transcription was performed in a Bio-Rad DNA Engine Peltier Thermal Cycler PTC0200 (Bio-Rad, Her- 
Leptin Receptor Real-Time PCR
Different controls were set to monitor the possible contamination of genomic and environmental DNA both at the stage of reverse transcription and PCR. The pooled sample made by mixing an equal quantity of total RNA from all samples was used for optimizing the PCR condition and tailoring the standard curve. Two microliters of 5-fold dilution of each reverse transcriptase product was used for PCR in a final volume of 25 μL. The end products of PCR were verified with the melting curves that show a single peak specific for the target gene.
Statistical Analysis
The method of 2 -DDC T was used to analyze the realtime PCR data expressed as the fold change relative to the control group (Livak and Schmittgen, 2001) . All data were presented as means ± SEM. Statistical analyses were carried out with SPSS 11.0 for Windows (SPSS Inc., Chicago, IL). The differences were tested with ANOVA using a t-test for independent samples. A P-value less than 0.05 was considered significant.
RESULTS
Laying Performance
During 8 wk of dietary treatment, cysteamine increased the average laying rate by 2.24% (P < 0.01), decreased the percentage of broken eggs by 40.55% (P < 0.01), and increased the percentage of abnormal eggs by 20.15% (P < 0.05; Table 2 ). Dietary cysteamine did not affect body weight, liver or oviduct weight of hens, nor fertility or hatchability of their eggs (data not shown). However, an increase in eggshell weight (P < 0.05) and a decrease in albumin weight (P < 0.05) were observed in eggs laid by cysteamine-treated hens (Table 3) .
Offspring Growth
Maternal exposure of cysteamine induced a sexual dimorphic effect on the hatch weight and early posthatch growth of offspring (Table 4) . Female chicks in a cysteamine-exposed group exhibited significantly lower hatch weight (P < 0.01) and body weight (P < 0.01) at 42 d of age, whereas no effect was seen in male chicks.
Hormone Concentrations
Serum concentrations of T 4 (P < 0.01) and leptin (P < 0.01) were significantly lower in cysteamine-treated hens, whereas T 3 , free T 3 , and glucagon were not affected (Table 5 ). Dietary cysteamine did not affect the yolk content of T 3 , T 4 , E 2 , or glucagon but significantly increased leptin content in liver (P < 0.05), yolk (P < 0.05), and albumin (P < 0.05) of eggs (Table 6 ). Western blot analysis with leptin-specific antibody detected a band of approximately 15 to 16 kDa in egg yolk and albumin extracts (Figure 1) , as well as liver homogenates of hens. Quantification by the band density ratios of leptin relative to β-actin (Figure 2A ) confirmed the results from RIA. The liver of cysteamine-treated hens contained significantly greater (P < 0.05) leptin compared with that of the control ( Figure 2B ).
Leptin Receptor mRNA Expression
Expression of leptin receptor gene mRNA in the yolk sac of d-12 embryos was detected with real-time PCR. A significant downregulation (P < 0.05) was observed in the cysteamine-treated group (Figure 3) .
DISCUSSION
The present study demonstrated that cysteamine, supplemented to the broiler breeder diet during the late (postpeak) stage of laying cycle, improves egglaying rate but attenuates the offspring growth in a sex-specific manner. The slightly yet significantly increased egg-laying rate could be the direct effect of cysteamine, because cysteamine has been reported to increase glutathione synthesis and hence promote the maturation of oocytes in vitro (Urdaneta et al., 2004) . However, the positive effect of dietary cysteamine on egg production could also be a consequence of modified endocrine status.
In the present study, serum concentrations of T 4 and leptin were significantly decreased in cysteaminetreated hens. Thyroxine is commonly known to inhibit gonadal function and induce molting in laying hens (Sekimoto et al., 1987; Hoshino et al., 1988) ; the decreased serum T 4 concentration in cysteamine-treated hens may reflect attenuated regression of ovarian follicles and delayed cessation of egg production. The association between serum leptin concentration and egg production is less clear. Exogenous leptin attenuated the follicular apoptosis induced by starvation in laying hens (Paczoska-Eliasiewicz et al., 2003) , and long-term immunization against leptin significantly depressed the laying rate of hens (Shi et al., 2006) , supporting a positive effect of leptin in laying performance. The negative association between improved laying rate and decreased leptin concentration in cysteamine-treated hens does not agree with the results obtained from the intervention of the endogenous leptin system. However, because serum levels of T 4 and leptin were reported to be correlated, respectively, with the carcass percentages of protein and fat in the chicken (Sun et al., 2006) , the decreased T 4 and leptin may indicate enhanced mobilization of body protein and fat to meet with the energy requirement for increased egg-laying rate.
The endocrine status of the laying female may influence the hormonal profiles in the yolk of avian eggs (Adkins-Reagan, 1995) . By far, most of the work on yolk deposition of maternal hormones concerns steroid (Groothuis et al., 2005) or thyroid (Wilson and McNabb, 1997) hormones, few on protein hormones. The present study provides the first evidence for the presence of leptin in the yolk and albumin of avian eggs. Moreover, it is noteworthy that leptin deposition was significantly increased in the eggs laid by cysteamine-treated hens with reduced serum leptin concentrations, whereas Values are means ± SEM. FT 3 = free triiodothyronine; T 3 = triiodothyronine; T 4 = thyroxine. **P < 0.01, n = 10, compared with control. no changes were detected for deposition of other hormones, including T 3 , T 4 , E 2 , and glucagon. The correlation of hormone levels between maternal blood and yolk is inconsistent. Although the mechanism of hormone deposition in the yolk has not been clarified so far, it is conceivable that the deposition of maternal hormones in the yolk is regulated independently from the maternal blood levels (Groothuis et al., 2005) . In the chicken, leptin is expressed in various tissues including liver and adipose tissue, under tissuespecific hormonal regulation (Ashwell et al., 1999) . Leptin mRNA and protein has been detected in human preovulatory follicles (Cioffi et al., 1997) and follicular fluid (Wunder et al., 2005) , respectively. Chicken ovary has not yet been reported to express leptin, but high levels of leptin receptor (cOb-R) mRNA expression were observed in the ovary of chickens mediating the direct effect of leptin on ovarian functions (Cassy et al., 2004; Sirotkin and Grossmann, 2007) . The leptin detected in the egg could be derived from maternal circulation through a specifically regulated transport mechanism, which is independent of maternal leptin level, or secreted directly from ovarian or oviduct cells. Because somatostatin is reported to inhibit the leptinsignaling pathway in rat hypothalamus (Stepanyan et al., 2007) , it is possible that cysteamine may affect leptin secretion or leptin transport system, or both, in the chicken during its egg deposition through depletion of endogenous somatostatin.
Hepatic expression of leptin in chicken is most likely associated with the primary role of this organ in lipogenesis (Taouis et al., 2001) . It is interesting that liver content of leptin actually increased in cysteaminetreated hens with lower serum leptin concentration. It could have resulted from inhibited release of leptin from liver or a feedback effect of lower circulating leptin on hepatic leptin synthesis.
Maternal exposure to cysteamine negatively affected the hatch weight and attenuated early posthatch growth of female offspring. Previous experiments showed no significant adverse effect of maternal cysteamine exposure at the level of 75 mg/kg per day or lower, yet intrauterine growth retardation and fetal death were seen at 100 to 150 mg/kg per day from d 6.5 through 18.5 postconception in rats Beckman et al., 1998) . The growth-promoting dose of cysteamine is only 5 to 10 mg/kg per day, at which level the direct developmental toxicity may not exist. However, the developmental programming induced indirectly by modified endocrine status cannot be ruled out.
Dietary cysteamine did not alter the egg weight, egg quality, fertility, or hatchability but significantly increased eggshell weight and decreased albumin weight, implicating a direct or indirect effect of cysteamine on oviduct function in the chicken. It is possible that cysteamine altered the transition rate of the yolk through magnus and uterus of the oviduct, where the albumin and eggshell formation takes place, respectively. The decrease of the broken egg rate and the increase of the abnormal egg rate observed in the cysteamine-treated group could be the consequence of such effect. The alterations in the egg composition may partly account for the maternal effect of cysteamine, yet increased yolk and albumin concentration of leptin may participate in programming the offspring growth.
Leptin has been implicated to play an important role in the programming of offspring performance in mammals (McMillen et al., 2006 ), yet studies in avian species are scarce. Injection of recombinant mice leptin into the albumin of eggs on d 5 of incubation advanced hatching by 5 to 24 h and improved growth rate in quails during 56 d posthatching, suggesting a role of leptin in eggs in the regulation of posthatch growth (Lamosova et al., 2003) . Our result seems to contradict with that of the quails, because the yolk leptin concentration inversely correlated with the hatch weight and posthatch growth in female offspring. However, multiple factors including differences in species or the experimental designs, or both, may contribute to the divergence of the results. The significant downregulation of leptin receptor mRNA expression in the yolk sac of cysteamine-treated embryos may contribute to the maternal influence of cysteamine in offspring growth, either directly through leptin transportation across yolk sac membrane or indirectly through modification of yolk sac functions.
No explanation is available, at the moment, for the sex-specific effect of maternal cysteamine exposure observed in the present study. It is presumed that leptin may interact with the regulatory components involved in sex determination and sex development of females, so as to affect the embryonic and posthatch development of female chickens.
In summary, the present study demonstrated a positive effect of dietary cysteamine on laying performance of broiler breeder hens but a sex-specific negative influence on hatch weight and early posthatch growth of female offspring. Furthermore, leptin is detected for the first time in eggs, and there is evidence pointing to its involvement in mediating the maternal effect of cysteamine on offspring growth in broiler chickens.
